Multiple Sclerosis in US Veterans of the Vietnam Era and Later Military Service: Race, Sex, and Geography

Annals of Neurology

Volumn 55, Issue 1, 2004, Pages 65-71

  Wallin, Mitchell T ^a,c   Page, William F ^b   Kurtzke, John F ^a  

^a GEORGETOWN UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b NATIONAL ACADEMY OF SCIENCES   (United States)

^c VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CASE CONTROL STUDY; COMPARATIVE STUDY; CONTROLLED STUDY; ENVIRONMENTAL FACTOR; FEMALE; GEOGRAPHY; HIGH RISK POPULATION; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTIPLE SCLEROSIS; PRIORITY JOURNAL; RACE; RISK FACTOR; SEX DIFFERENCE; SOLDIER; UNITED STATES; VIET NAM;

CASE-CONTROL STUDIES; CONTINENTAL POPULATION GROUPS; FEMALE; HUMANS; MALE; MULTIPLE SCLEROSIS; RISK FACTORS; SEX FACTORS; UNITED STATES; VETERANS; VIETNAM;

EID: 0346688789     PISSN: 03645134     EISSN: None     Source Type: Journal    
DOI: 10.1002/ana.10788     Document Type: Article

References (30)

1. Anderson DW, Ellenberg JH, Leventhal CM, et al. Revised estimate of prevalence of multiple sclerosis in the United States. Ann Neurol 1992;31:333-336.
2. Kurtzke JF, Beebe GW, Norman JE Jr, et al. Epidemiology of multiple sclerosis in US veterans. 1. Race, sex, and geographic distribution. Neurology 1979;29:1228-1235.
3. Norman JE Jr, Kurtzke JF, Beebe GW. Epidemiology of multiple sclerosis in US veterans. 2. Latitude, climate and the risk of multiple sclerosis. J Chronic Dis 1983;36:551-559.
4. Kurtzke JF, Beebe GW, Norman JE Jr. Epidemiology of multiple sclerosis in US veterans. III. Migration and the risk of MS. Neurology 1985;35:672-678.
5. Kurtzke JF, Page WF, Murphy FM, et al. Epidemiology of multiple sclerosis in US veterans. IV. Age at onset. Neuroepidemiology 1992;11:226-235.
6. Page WF, Kurtzke JF, Murphy FM, et al. Epidemiology of multiple sclerosis in US veterans. V. Ancestry and the risk of multiple sclerosis. Ann Neurol 1993;33:632-639.
7. Page WF, Mack TM, Kurtzke JF, et al. Epidemiology of multiple sclerosis in US veterans. VI. Population ancestry and surname ethnicity as risk factors for multiple sclerosis. Neuroepidemiology 1995;14:286-296.
8. Kurtzke JF, Page WF. Epidemiology of multiple sclerosis in US veterans. VII. Risk factors for MS. Neurology 1997;48:204-213.
9. Wallin MT, Page WF, Kurtzke JF. Epidemiology of multiple sclerosis in US veterans. VIII. Long-term survival after onset of multiple sclerosis. Brain 2000;123:1677-1687.
10. Klein RE. Period of service in Veteran Population 2001 adjusted to Census 2000. VA Special Topic Report, September 30, 2002. Available at: http://www.va.gov/vetdata/demographics/; accessed 6/1/2003.
11. Schumacher GA, Beebe GW, Kibler RF, et al. Problems of experimental trials of therapy in multiple sclerosis: report by the panel on the evaluation of experimental trial of therapy in multiple sclerosis. Ann NY Acad Sci 1965;122:552-568.
12. Poser CM, Paty DW, Scheinberg L, et al. New diagnostic criteria for multiple sclerosis: guidelines for research protocols. Ann Neurol 1983;13:227-231.
13. SAS Institute. SAS procedures guide. Release 6.03 edition. Cary, NC: SAS Institute, 1988.
14. Mirsattari SM, Johnston JB, McKenna R, et al. Aboriginals with multiple sclerosis: HLA types and predominance of neuromyelitis optica. Neurology 2001;56:317-323.
15. Grønlie SA, Myrvøll E, Hansen G, et al. Multiple sclerosis in North Norway, and first appearance in an indigenous population. J Neurol 2000;247:129-133.
16. Kurtzke JF, Wallin MT. Epidemiology. In: Multiple sclerosis: diagnosis, medical management, and rehabilitation. Burks JS, Johnson KP, eds. New York: Demos Press, 2000:49-71.
17. Pryse-Phillips WEM. The incidence and prevalence of multiple sclerosis in Newfoundland and Labrador, 1960-1984. Ann Neurol 1986;20:323-328.
18. Hammond SR, McLeod JG, Millingen KS, et al. The epidemiology of multiple sclerosis in three Australian cities: Perth, Newcastle and Hobart. Brain 1988;111:1-25.
19. Lauer K. Multiple sclerosis in the old world. The new old map. In: Multiple sclerosis in Europe. An epidemiological update. Firnhaber W, Lauer K, eds. Darmstadt: LTV Press, 1994:219-230.
20. Sumelahti ML, Tienari PG, Wikstrom J, et al. Regional and temporal variation in the incidence of multiple sclerosis in Finland 1979-1993. Neuroepidemiology 2000;19:67-75.
21. Kurtzke JF. Multiple sclerosis in time and space-geographic clues to cause. J Neurovirol 2000;6:S134-S140.
22. Forbes RB, Swingler RJ. Estimating the prevalence of multiple sclerosis in the United Kingdom by using capture-recapture methodology. Am J Epidemiol 1999;149:1016-1024.
23. Robertson N, Compston A. Surveying multiple sclerosis in the United Kingdom. J Neurol Neurosurg Psychiatry 1995;58:2-6.
24. Forbes RB, Wilson SV, Swinger RJ. The prevalence of multiple sclerosis in Tayside, Scotland: do latitude gradients really exist? J Neurol 1999;246:1033-1040.
25. Savettieri G, Ragonese P, Aridon P, et al. Epidemiology of multiple sclerosis in Sicily. Neurol Sci 2001;22:175-177.
26. Kurtzke JF. Epidemiology of multiple sclerosis. Does this really point toward an etiology? Lectio Doctoralis. Neurol Sci 2000;21:383-403.
27. Waters MC. Immigration, intermarriage, and the challenges of measuring racial/ethnic identities. Am J Public Health 2000;90:1735-1737.
28. Reitnauer PG, Go RC, Acton RT, et al. Evidence for genetic admixture as a determinant in the occurrence of insulin-dependent diabetes mellitus in U.S. blacks. Diabetes 1982;31:532-537.
29. Harrison R, Bennett C. Racial and ethnic diversity. In: Farley R, ed. State of the Union: America in the 1990s. Vol 2. Social Trends. New York: Russell Sage Foundation Press, 1995:165.
30. Noonan CW, Kathman SJ, White MC. Prevalence estimates for MS in the United States and evidence of an increasing trend for women. Neurology 2002;58:136-138.